Age-related Macular Degeneration Market by Product (Lucentis, Beovu, Eyelea), Disease Type (Wet AMD, Dry AMD), Route of Administration (Intravitreal, Intravenous), Distribution Channel (Hospital Pharmacy, Online Pharmacy), and by Region - Global Forecast to 2022-2033

The age-related macular degeneration market size is estimated to be USD 9,875.2 million in 2022 and is expected to witness a CAGR of 7.12% during the forecast period 2023-2033. Increasing R&D investments, expanding geriatric population, surging number of people with retinal disorders, product launch and approval, and medicines for the treatment of dry AMD are factors contributing to the market growth. However, rising off-label use of pharmaceuticals and lack of knowledge about the disease is expected to hinder the growth.

Surging number of people with retinal disorders is expected to stimulate the market growth. According to statistics, the market expansion is significantly associated with the rising number of people suffering from retinal problems. Thus, the growing prevalence of these conditions is fuelling demand for macular degeneration treatments, which is further boosting market growth.

Product approval and launch is predicted to propel the market growth. For the treatment of wet AMD, myopic choroidal neovascularization, and retinal vein occlusion, Biogen Inc. and Samsung Bioepis Co., Ltd. acquired U.S. FDA approval for their biosimilar version of Lucentis in September 2021 under the brand name BYOOVIZ. However, in June 2022, the product was launched in U.S. due to required additional protection certificates. In August 2021, the product also obtained approval in EU nations, including the UK.

Segmentation

 

 By Product

The market is categorized into lucentis, beovu, eyelea, and others. In the global market, the eyelea segment accounted for the largest revenue share in 2022 owing to the increased market penetration and patent protection. Additionally, patients taking Beovu reported four times greater intraocular inflammation than those taking eylea, according to study studies. Lucentis is anticipated to hold the biggest market share over the future years due to introduction of a novel drug delivery method.

 By Disease Type

The market is bifurcated into wet AMD and dry AMD. In 2022, the wet AMD segment accounted for the highest revenue share due to growing geriatric population around the world as AMD is the most common cause of substantial loss of vision in people over 50. Dry AMD is predicted to experience the fastest growth throughout the forecast period owing to planned introduction of potential product candidates.

 By Route of Administration

The market is divided into intravitreal and intravenous. In the global market, the intravitreal segment accounted for the largest revenue share in 2022 owing to its more effective method of medication administration. Additionally, increasing adoption of intravitreal route of administration in major regions to expected to support the market growth. Moreover, intravitreal injections are used to provide the majority of anti-VEGF injections.

By Distribution Channel

The market is segmented into hospital pharmacy, online pharmacy, specialty pharmacy. In 2022, the hospital pharmacy segment accounted for the largest revenue share owing to increase in age-related macular degeneration (AMD) incidence and hospitalisation for treatment. Specialty pharmacy segment is anticipated to experience the quickest growth throughout the projection period due to simplicity of drug availability and reimbursement coverage provided by specialty pharmacies. simplicity of drug availability and reimbursement coverage provided by specialty pharmacies

Regional Markets

In 2022, North America region accounted for the highest revenue in the age-related macular degeneration market and is expected to maintain its dominance during the forecast period. This is attributed to the rising incidence of AMD. Around 15 million people in North America have AMD, according to the American Academy of Ophthalmology. In 2021, Europe had the second-largest market share. This is because macular degeneration is extremely common in Europe and is expected to increase by about 20% by the year 2050. Asia Pacific is anticipated to experience the quickest growth during the projection period due to large geriatric population and disease burden. The market growth can be influenced by the positive government actions to help the affordability of pricey anti-VEGF medications.

Competitor Insights

Some of the key players operating in the age-related macular degeneration market are Acucela Inc., ALLERGAN, Santen Pharmaceuticals Co., Bausch & Lomb Incorporated, Bayer AG, Novartis AG, F. Hoffmann La Roche, GlaxoSmithKline PLC, Ophthotech Corporation, Pfizer Inc, Alimera Sciences Inc., Rxi Pharmaceuticals Inc., Ocular Therapeutix Regeneron Pharmaceuticals, Mosaic Biosciences,  and Valeant Pharmaceuticals International, Inc. among others.

Companies are forming a variety of strategic agreements to expand in different areas. Research spending have escalated in an effort to create AMD treatments.

  • A collaboration between Mosaic Biosciences and Ocular Therapeutix was established in 2021 with the goal of improving treatments for dry age-related macular degeneration.
  • In 2021, Bioeq and Teva Pharmaceuticals formed a business alliance to develop medicines for ophthalmology.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, disease type, route of administration, and distribution channel from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 9,875.2 Million
CAGR
  • 7.12%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Product
  • Disease Type
  • Route of Administration
  • Distribution Channel
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Age-related Macular Degeneration Market Report 2022 – 2033

Product (Revenue, USD Million), 2022 – 2033

  • Lucentis
  • Beovu
  • Eyelea
  • Others

Disease Type (Revenue, USD Million), 2022 – 2033

  • Wet AMD
  • Dry AMD

Route of Administration (Revenue, USD Million), 2022 – 2033

  • Intravitreal
  • Intravenous

Distribution Channel (Revenue, USD Million), 2022 – 2033

  • Hospital Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Age-related Macular Degeneration Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Age-related Macular Degeneration
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Age-related Macular Degeneration Market  
  3. Market Analysis by Product
    1. Lucentis
      1. Lucentis Market Forecast, 2022-2033(USD Million)
    2. Beovu
      1. Beovu Market Forecast, 2022-2033(USD Million)
    3. Eyelea
      1. Eyelea Market Forecast, 2022-2033(USD Million)
    4. Others
      1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Disease Type
    1. Wet AMD
      1. Wet AMD Market Forecast, 2022-2033(USD Million)
    2. Dry AMD
      1. Dry AMD Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Route of Administration  
    1. Intravitreal
      1. Intravitreal Market Forecast, 2022-2033(USD Million)
    2. Intravenous
      1. Intravenous Market Forecast, 2022-2033(USD Million)
  1. Market Analysis by Distribution Channel
    1. Hospital Pharmacy
      1. Hospital Pharmacy Market Forecast, 2022-2033(USD Million)
    2. Online Pharmacy
      1. Online Pharmacy Market Forecast, 2022-2033(USD Million)
    3. Specialty Pharmacy
      1. Specialty Pharmacy Market Forecast, 2022-2033(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North AmericaAge-related Macular Degeneration Market  
    1. North AmericaAge-related Macular Degeneration Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. S.Age-related Macular Degeneration Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. CanadaAge-related Macular Degeneration Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. EuropeAge-related Macular Degeneration Market  
    1. EuropeAge-related Macular Degeneration Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. GermanyAge-related Macular Degeneration Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. UKAge-related Macular Degeneration Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. FranceAge-related Macular Degeneration Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
              3. Market Size and Forecast byRoute of Administration, 2022-2033 (USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
            2. SpainAge-related Macular Degeneration Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Product, 2022-2033(USD Million)
                2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
                3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
              2. ItalyAge-related Macular Degeneration Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Product, 2022-2033(USD Million)
                  2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                  4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
                2. Rest of EuropeAge-related Macular Degeneration Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Product, 2022-2033(USD Million)
                    2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                    4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. Asia PacificAge-related Macular Degeneration Market  
    1. Asia PacificAge-related Macular Degeneration Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. JapanAge-related Macular Degeneration Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. ChinaAge-related Macular Degeneration Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. IndiaAge-related Macular Degeneration Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
              3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
            2. South KoreaAge-related Macular Degeneration Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Product, 2022-2033(USD Million)
                2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
                3. Market Size and Forecast by Route of Administration,2022-2033 (USD Million)
                4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
              2. AustraliaAge-related Macular Degeneration Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Product, 2022-2033(USD Million)
                  2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
                  3. Market Size and Forecast by Route of Administration 2022-2033(USD Million)
                  4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
                2. Rest of Asia PacificAge-related Macular Degeneration Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Product, 2022-2033(USD Million)
                    2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
                    3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                    4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. Latin America Age-related Macular Degeneration Market  
    1. Latin AmericaAge-related Macular Degeneration Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. BrazilAge-related Macular Degeneration Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. MexicoAge-related Macular Degeneration Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. ArgentinaAge-related Macular Degeneration Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
              3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
            2. Rest of Latin AmericaAge-related Macular Degeneration Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Product, 2022-2033(USD Million)
                2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
                3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
                4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. MEAAge-related Macular Degeneration Market  
    1. MEAAge-related Macular Degeneration Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Product, 2022-2033(USD Million)
        2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
        3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
        4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
      2. GCCAge-related Macular Degeneration Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Product, 2022-2033(USD Million)
          2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
          3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
          4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
        2. South AfricaAge-related Macular Degeneration Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Product, 2022-2033(USD Million)
            2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
            3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
            4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
          2. Rest of MEAAge-related Macular Degeneration Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Product, 2022-2033(USD Million)
              2. Market Size and Forecast by Disease Type, 2022-2033 (USD Million)
              3. Market Size and Forecast by Route of Administration, 2022-2033(USD Million)
              4. Market Size and Forecast byDistribution Channel, 2022-2033 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Acucela Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    2. ALLERGAN
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    3. Santen Pharmaceuticals Co.
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    4. Bausch & Lomb Incorporated
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    5. Bayer AG
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    6. Novartis AG
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    7. Hoffmann La Roche
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    8. GlaxoSmithKline PLC
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    9. Ophthotech Corporation
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    10. Pfizer Inc
      1. Company Snapshot
      2. Company Overview
      3. Financial Analysis
      4. Product Benchmarking
      5. Recent Developments
    11. Alimera Sciences Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    12. Rxi Pharmaceuticals Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    13. Regeneron Pharmaceuticals
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    14. Valeant Pharmaceuticals International, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.